WINLEVI (Sun Pharma ANZ Pty Ltd)
Product name
WINLEVI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
194 (255 working days)
Active ingredients
clascoterone
Registration type
NCE/NBE
Indication
WINLEVI (clascoterone) cream is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.